Title | Concomitant assessment of PD-1 and CD56 expression identifies subsets of resting cord blood Vδ2 T cells with disparate cytotoxic potential. |
Publication Type | Journal Article |
Year of Publication | 2024 |
Authors | Hsu H, Zanettini C, Coker M, Boudova S, Rach D, Mvula G, Divala TH, Mungwira RG, Boldrin F, Degiacomi G, Mazzabò LCioetto, Manganelli R, Laufer MK, Zhang Y, Marchionni L, Cairo C |
Journal | Cell Immunol |
Volume | 395-396 |
Pagination | 104797 |
Date Published | 2024 Jan-Feb |
ISSN | 1090-2163 |
Keywords | CD56 Antigen, CD8-Positive T-Lymphocytes, Cytokines, Cytotoxicity, Immunologic, Fetal Blood, Humans, Perforin, Programmed Cell Death 1 Receptor, Receptors, Antigen, T-Cell, gamma-delta, T-Lymphocyte Subsets |
Abstract | Vγ9Vδ2 T lymphocytes are programmed for broad antimicrobial responses with rapid production of Th1 cytokines even before birth, and thus thought to play key roles against pathogens in infants. The process regulating Vδ2 cell acquisition of cytotoxic potential shortly after birth remains understudied. We observed that perforin production in cord blood Vδ2 cells correlates with phenotypes defined by the concomitant assessment of PD-1 and CD56. Bulk RNA sequencing of sorted Vδ2 cell fractions indicated that transcripts related to cytotoxic activity and NK function are enriched in the subset with the highest proportion of perforin+ cells. Among differentially expressed transcripts, IRF8, previously linked to CD8 T cell effector differentiation and NK maturation, has the potential to mediate Vδ2 cell differentiation towards cytotoxic effectors. Our current and past results support the hypothesis that distinct mechanisms regulate Vδ2 cell cytotoxic function before and after birth, possibly linked to different levels of microbial exposure. |
DOI | 10.1016/j.cellimm.2023.104797 |
Alternate Journal | Cell Immunol |
PubMed ID | 38157646 |
Grant List | R01 AI104702 / AI / NIAID NIH HHS / United States U01 AI087624 / AI / NIAID NIH HHS / United States U01 HD092308 / HD / NICHD NIH HHS / United States P30 CA134274 / CA / NCI NIH HHS / United States |
Related Faculty:
Luigi Marchionni, M.D., Ph.D.